ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors.

Tae Won Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.